New Delhi [India], June 14: The Fondazione Ricerca e Innovazione Cardiovascolare (RIC) has successfully finished patient enrolment for TRANSFORM II, one of the most ambitious and extensive randomised controlled trials (RCTs) ever carried out in the field of cardiovascular care, at a pivotal point for the future of interventional cardiology.
Friday, February 6
Trending
- Travels and Rentals Ltd Announces Rs 16.80 Crore Rights Issue; Record Date Set for Jan 28
- Seema Singh, Raaj Shaandilyaa, Amit Rai and Saurabh Varma Esteemed Jury Members for Iconic Gold Awards 2026
- A New Voice Makes Old Basrur Sparkle: Gautham V Kedoor’s Rise in Indian Popular Fiction
- Ducon’s Early Carbon Capture Strategy Receives Policy Validation as India Accelerates CCUS Deployment
- Blissful Backpack Headlines Today’s KRAFTON India BGMI Redeem Code Drop
- Patel Retail Limited Delivers Strong Q3 FY26 Performance with 36 Percent Revenue Growth and 96 Percent Surge in Profit
- MFins Services Records Strong Growth in Solar and EV Charging Business, Expands Pan-India Footprint
- Standard Engineering Technology Limited Delivers Strong Q3 and 9M FY26 Performance
